Among early stage ovarian cancer patients who underwent complete cytoreductive surgery including systematic pelvic and para-aortic lymphadenectomy, the association between the expression of CLU protein in ovarian cancer tissues and several clinicopathological factors revealed that age (p = 0.83), histologic subtype (p = 0.32) were not related to CLU expression, while FIGO stage showed the relation to CLU expression with marginal significance (p = 0.09) (Table 3). The gene discussed is CLU; the disease is ovarian carcinoma.